Pagina 2 - U.S. Groei aandelen Pharmaceuticals & Biotech

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Jun 14, 2026

Ontdek U.S. Pharmaceuticals & Biotech Groeiaandelen die op de NYSE en NASDAQ staan. Gesorteerd op voorspelde groei, hebben deze Pharmaceuticals & Biotech Stocks een hoger dan verwachte winst- of omzetgroei in vergelijking met andere bedrijven.

712 bedrijven

Bedrijf	Laatste prijs	7D Terugkeer	1 J Rendement	Marktkapitalisatie	Doel analisten	Waardering	Groei	Div Opbrengst
PRTA	US$8.25	-3.6%	45.8%	US$431.9m	US$21.40	7.5	71.8%	n/a
MIRM	US$99.35	6.2%	97.0%	US$6.1b	US$144.93	10.6	71.8%	n/a
RARE	US$24.35	12.8%	-34.4%	US$2.4b	US$52.05	3.6	71.4%	n/a
YCBD	US$0.69	-4.7%	-20.0%	US$7.2m	US$2.00	0.8	71.3%	n/a
TLSI	US$3.77	17.4%	-31.6%	US$231.5m	US$8.80	5.2	70.7%	n/a
OCGN	US$1.21	-4.0%	4.3%	US$409.6m	US$11.43	91.7	70.3%	n/a
SRRA	US$54.99	0.06%	179.4%	US$1.3b	US$55.00	5.1	69.5%	n/a
MRKR	US$1.38	-5.5%	-9.2%	US$23.0m	US$7.87	6.5	69.0%	n/a
SNDX	US$18.25	7.6%	82.7%	US$1.6b	US$39.00	7.4	68.2%	n/a
HRTX	US$0.40	-11.8%	-80.3%	US$75.7m	US$3.00	9.4	67.9%	n/a
CTXR	US$0.54	-8.4%	-31.7%	US$14.8m	US$4.00	2.6	67.9%	n/a
ANIK	US$14.72	0.8%	32.5%	US$195.9m	US$17.50	1.7	67.6%	n/a
BCRX	US$8.70	3.2%	-15.5%	US$2.2b	US$21.30	2.5	67.4%	n/a
MAIA	US$1.30	2.4%	-24.4%	US$79.0m	US$12.14	2.8	67.3%	n/a
GOSS	US$0.16	-2.2%	-87.4%	US$38.0m	US$4.46	-0.2	67.1%	n/a
IOVA	US$4.08	2.0%	96.2%	US$1.8b	US$8.80	6.4	67.1%	n/a
NTLA	US$12.11	-10.2%	35.2%	US$1.7b	US$26.63	25.6	67.0%	n/a
PRAX	US$266.58	5.3%	508.5%	US$7.4b	US$627.59	5.3	67.0%	n/a
INSM	US$97.85	3.9%	-3.7%	US$21.2b	US$197.62	25.9	66.9%	n/a
CELZ	US$2.17	0.03%	1.4%	US$8.0m	US$20.00	2673.9	66.8%	n/a
IXHL	US$3.83	12.6%	-38.7%	US$45.8m	US$17.93	0.6	66.7%	n/a
EOLS	US$6.73	0.7%	-32.4%	US$443.2m	US$14.67	1.5	66.7%	n/a
MNOV	US$1.23	-5.4%	-7.5%	US$60.5m	US$9.00	101.5	66.7%	n/a
RYTM	US$88.38	2.9%	41.7%	US$6.1b	US$138.20	27.9	66.3%	n/a

Page 2 of 30